{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:14:56Z","timestamp":1772050496282,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB969 project C01"],"award-info":[{"award-number":["SFB969 project C01"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Valosin-containing protein (VCP)\/p97 has emerged as a central regulator of the ubiquitin\u2013proteasome system by connecting ubiquitylation and degradation. The development of CB-5083, an ATPase D2-domain-selective and orally bioavailable inhibitor of VCP\/p97, allows targeting of the ubiquitin\u2013proteasome system in human diseases. In this study, we evaluated the effect of CB-5083 on the immune response in mice by using the lymphocytic choriomeningitis virus (LCMV) as an infection model. We demonstrate that LCMV infection increased the susceptibility to CB-5083 treatment in a CD8-independent manner. Administration of CB-5083 to mice reduced the cytotoxic T cell response and impaired viral clearance. Compared to uninfected cells, CB-5083 treatment enhanced the unfolded protein response in LCMV-infected cells. Administration of CB-5083 during the expansion of CD8<jats:sup>+<\/jats:sup> T cells led to strong toxicity in mice within hours, which resulted in enhanced IL-6 levels in the serum and accumulation of poly-ubiquitinated proteins. Furthermore, we linked the observed toxicity to the specific formation of aggregates in the skeletal muscle tissue and the upregulation of both lactate dehydrogenase and creatine kinase in the serum.<\/jats:p>","DOI":"10.1038\/s41419-022-05461-w","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:05:50Z","timestamp":1669899950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Valosin-containing protein (VCP\/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1015-5925","authenticated-orcid":false,"given":"Marta","family":"del Rio Oliva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9428-2349","authenticated-orcid":false,"given":"Michael","family":"Basler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"5461_CR1","first-page":"3877","volume":"127","author":"H Meyer","year":"2014","unstructured":"Meyer H, Weihl CC. The VCP\/p97 system at a glance: connecting cellular function to disease pathogenesis. J Cell Sci. 2014;127:3877\u201383.","journal-title":"J Cell Sci"},{"key":"5461_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bbrc.2015.05.111","volume":"463","author":"C Song","year":"2015","unstructured":"Song C, Wang Q, Song C, Rogers TJ. Valosin-containing protein (VCP\/p97) is capable of unfolding polyubiquitinated proteins through its ATPase domains. Biochem Biophys Res Commun. 2015;463:453.","journal-title":"Biochem Biophys Res Commun"},{"key":"5461_CR3","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1074\/jbc.273.6.3562","volume":"273","author":"RM Dai","year":"1998","unstructured":"Dai RM, Chen E, Longo DL, Gorbea CM, Li C, chi H. Involvement of valosin-containing protein, an ATPase co-purified with I\u03baB\u03b1 and 26S proteasome, in ubiquitin-proteasome- mediated degradation of I\u03baB\u03b1. J Biol Chem. 1998;273:3562\u201373.","journal-title":"J Biol Chem"},{"key":"5461_CR4","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1074\/jbc.M309938200","volume":"279","author":"Y Elkabetz","year":"2004","unstructured":"Elkabetz Y, Shapira I, Rabinovich E, Bar-Nun S. Distinct steps in dislocation of luminal endoplasmic reticulum-associated degradation substrates. Roles of endoplasmic reticulum-bound p97\/Cdc48p and proteasome. J Biol Chem. 2004;279:3980\u20139.","journal-title":"J Biol Chem"},{"key":"5461_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s42003-019-0283-z","volume":"2","author":"MM Olszewski","year":"2019","unstructured":"Olszewski MM, Williams C, Dong KC, Martin A. The Cdc48 unfoldase prepares well-folded protein substrates for degradation by the 26S proteasome. Commun Biol. 2019;2:29.","journal-title":"Commun Biol"},{"key":"5461_CR6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/nsb972","volume":"10","author":"B DeLaBarre","year":"2003","unstructured":"DeLaBarre B, Biology AB. Complete structure of p97\/valosin-containing protein reveals communication between nucleotide domains. Nat Struct Biol. 2003;10:856\u201363.","journal-title":"Nat Struct Biol"},{"key":"5461_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1042\/BST0360062","volume":"36","author":"HO Yeung","year":"2008","unstructured":"Yeung HO, Kloppsteck P, Niwa H, Isaacson RL, Matthews S, Zhang X, et al. Insights into adaptor binding to the AAA protein p97. Biochem Soc Trans. 2008;36:62\u20137.","journal-title":"Biochem Soc Trans"},{"key":"5461_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fmolb.2017.00021","volume":"4","author":"P H\u00e4nzelmann","year":"2017","unstructured":"H\u00e4nzelmann P, Schindelin H. The interplay of cofactor interactions and post-translational modifications in the regulation of the AAA+ ATPase p97. Front Mol Biosci. 2017;4:21.","journal-title":"Front Mol Biosci"},{"key":"5461_CR9","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1042\/BST0391509","volume":"39","author":"EB Taylor","year":"2011","unstructured":"Taylor EB, Rutter J. Mitochondrial quality control by the ubiquitin-proteasome system. Biochem Soc Trans. 2011;39:1509\u201313.","journal-title":"Biochem Soc Trans"},{"key":"5461_CR10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbadis.2016.11.026","volume":"1863","author":"X Guo","year":"2016","unstructured":"Guo X, Qi X. VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2016;1863:552\u20139.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5461_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ncb2407","volume":"14","author":"H Meyer","year":"2012","unstructured":"Meyer H, Bug M, Bremer S. Emerging functions of the VCP\/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol. 2012;14:117\u201323.","journal-title":"Nat Cell Biol"},{"key":"5461_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00412-016-0587-4","volume":"126","author":"K Ramadan","year":"2017","unstructured":"Ramadan K, Halder S, Wiseman K, Vaz B. Strategic role of the ubiquitin-dependent segregase p97 (VCP or Cdc48) in DNA replication. Chromosoma 2017;126:17\u201332.","journal-title":"Chromosoma"},{"key":"5461_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.molcel.2016.08.037","volume":"64","author":"J van den Boom","year":"2016","unstructured":"van den Boom J, Wolf M, Weimann L, Schulze N, Li F, Kaschani F, et al. VCP\/p97 extracts sterically trapped Ku70\/80 rings from DNA in double-strand break repair. Mol Cell. 2016;64:189\u201398.","journal-title":"Mol Cell"},{"key":"5461_CR14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/sj.emboj.7601600","volume":"26","author":"K Schweitzer","year":"2007","unstructured":"Schweitzer K, Bozko PM, Dubiel W, Naumann M. CSN controls NF-\u03baB by deubiquitinylation of I\u03baB\u03b1. EMBO J. 2007;26:1532.","journal-title":"EMBO J"},{"key":"5461_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1349-7006.2002.tb02172.x","volume":"93","author":"T Asai","year":"2002","unstructured":"Asai T, Tomita Y, Nakatsuka SI, Hoshida Y, Myoui A, Yoshikawa H, et al. VCP (p97) regulates NFKB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res. 2002;93:296.","journal-title":"Jpn J Cancer Res"},{"key":"5461_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng1332","volume":"36","author":"GDJ Watts","year":"2004","unstructured":"Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36:377\u201381.","journal-title":"Nat Genet"},{"key":"5461_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.nmd.2009.01.009","volume":"19","author":"CC Weihl","year":"2009","unstructured":"Weihl CC, Pestronk A, Kimonis VE. Valosin-containing protein disease: Inclusion body myopathy with Paget\u2019s disease of the bone and fronto-temporal dementia. Neuromuscul Disord. 2009;19:308\u201315.","journal-title":"Neuromuscul Disord"},{"key":"5461_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fonc.2016.00181","volume":"6","author":"PH Vekaria","year":"2016","unstructured":"Vekaria PH, Home T, Weir S, Schoenen FJ, Rao R. Targeting p97 to disrupt protein homeostasis in cancer. Front Oncol. 2016;6:181.","journal-title":"Front Oncol"},{"key":"5461_CR19","doi-asserted-by":"publisher","first-page":"9480","DOI":"10.1021\/acs.jmedchem.5b01346","volume":"58","author":"HJ Zhou","year":"2015","unstructured":"Zhou HJ, Wang J, Yao B, Wong S, Djakovic S, Kumar B, et al. Discovery of a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase (CB-5083). J Med Chem. 2015;58:9480\u201397.","journal-title":"J Med Chem"},{"key":"5461_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2015.10.002","volume":"28","author":"DJ Anderson","year":"2015","unstructured":"Anderson DJ, Le Moigne R, Djakovic S, Kumar B, Rice J, Wong S, et al. Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis. Cancer Cell. 2015;28:653\u201365.","journal-title":"Cancer Cell"},{"key":"5461_CR21","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1158\/1535-7163.MCT-17-0233","volume":"16","author":"R Le Moigne","year":"2017","unstructured":"Le Moigne R, Aftab BT, Djakovic S, Dhimolea E, Valle E, Murnane M, et al. The p97 inhibitor CB-5083 is a unique disrupter of protein homeostasis in models of Multiple Myeloma. Mol Cancer Ther. 2017;16:2375\u201386.","journal-title":"Mol Cancer Ther"},{"key":"5461_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006329","volume":"13","author":"YT Lin","year":"2017","unstructured":"Lin YT, Prendergast J, Grey F. The host ubiquitin-dependent segregase VCP\/p97 is required for the onset of human cytomegalovirus replication. PLoS Pathog. 2017;13:1\u201323.","journal-title":"PLoS Pathog"},{"key":"5461_CR23","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.3389\/fmicb.2019.02236","volume":"10","author":"G Carissimo","year":"2019","unstructured":"Carissimo G, Chan YH, Utt A, Chua TK, Bakar FA, Merits A, et al. VCP\/p97 is a proviral host factor for replication of chikungunya virus and other alphaviruses. Front Microbiol. 2019;10:2236.","journal-title":"Front Microbiol"},{"key":"5461_CR24","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1128\/JVI.00114-12","volume":"86","author":"M Arita","year":"2012","unstructured":"Arita M, Wakita T, Shimizu H. Valosin-containing protein (VCP\/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection. J Virol. 2012;86:5541\u201353.","journal-title":"J Virol"},{"key":"5461_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner AG. *Power 3: a flexible statistical power analysis program for the social, behavioral,and biomedical sciences. Behav Res Methods. 2007;39:175\u201391.","journal-title":"Behav Res Methods"},{"key":"5461_CR26","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.4049\/jimmunol.0901596","volume":"183","author":"M Basler","year":"2009","unstructured":"Basler M, Lauer C, Beck U, Groettrup M. The proteasome inhibitor bortezomib enhances the susceptibility to viral infection. J Immunol. 2009;183:6145\u201350.","journal-title":"J Immunol"},{"key":"5461_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","volume":"33","author":"M Battegay","year":"1991","unstructured":"Battegay M, Cooper S, Althage A, B\u00e4nziger J, Hengartner H, Zinkernagel RM. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods. 1991;33:191\u20138.","journal-title":"J Virol Methods"},{"key":"5461_CR28","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/eji.202249851","volume":"52","author":"M del Rio Oliva","year":"2022","unstructured":"del Rio Oliva M, Kirk CJ, Groettrup M, Basler M. Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome. Eur J Immunol. 2022;52:1510\u201322.","journal-title":"Eur J Immunol"},{"key":"5461_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/eji.201747282","volume":"48","author":"M Basler","year":"2018","unstructured":"Basler M, Mundt S, Groettrup M. The immunoproteasome subunit LMP7 is required in the murine thymus for filling up a hole in the T cell repertoire. Eur J Immunol. 2018;48:419\u201329.","journal-title":"Eur J Immunol"},{"key":"5461_CR30","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.173.6.3925","volume":"173","author":"M Basler","year":"2004","unstructured":"Basler M, Youhnovski N, Broek M, van den, Przybylski M, Groettrup M. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus. J Immunol. 2004;173:3925\u201334.","journal-title":"J Immunol"},{"key":"5461_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-385114-7.00004-0","volume":"490","author":"CM Oslowski","year":"2011","unstructured":"Oslowski CM, Urano F, Measuring ER stress and the unfolded protein response using mammalian tissue culture system. Methods Enzymol. 2011;490:71\u201392.","journal-title":"Methods Enzymol"},{"key":"5461_CR32","doi-asserted-by":"publisher","first-page":"F1046","DOI":"10.1152\/ajprenal.00350.2017","volume":"314","author":"DK Panda","year":"2018","unstructured":"Panda DK, Bai I, Sabbagh Y, Zhang Y, Zaun HC, Karellis A, et al. Defective interplay between mTORC1 activity and endoplasmic reticulum stress-unfolded protein response in uremic vascular calcification. Am J Physiol Ren Physiol. 2018;314:F1046\u201361.","journal-title":"Am J Physiol Ren Physiol"},{"key":"5461_CR33","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.4049\/jimmunol.179.6.3417","volume":"179","author":"TN Jorgensen","year":"2007","unstructured":"Jorgensen TN, McKee A, Wang M, Kushnir E, White J, Refaeli Y, et al. Bim and Bcl-2 mutually affect the expression of the other in T cells. J Immunol. 2007;179:3417\u201324.","journal-title":"J Immunol"},{"key":"5461_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4528","volume":"5","author":"M Shao","year":"2014","unstructured":"Shao M, Shan B, Liu Y, Deng Y, Yan C, Wu Y, et al. Hepatic IRE1\u03b1 regulates fasting-induced metabolic adaptive programs through the XBP1s-PPAR\u03b1 axis signalling. Nat Commun. 2014;5:3528.","journal-title":"Nat Commun"},{"key":"5461_CR35","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1038\/onc.2008.201","volume":"27","author":"S Lukasiak","year":"2008","unstructured":"Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF, et al. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 2008;27:6068\u201374.","journal-title":"Oncogene"},{"key":"5461_CR36","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/eji.1830190720","volume":"19","author":"A Wille","year":"1989","unstructured":"Wille A, Gessner A, Lother H, Lehmann\u2010Grube F. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus\u2010infected mice with anti\u2010interferon\u2010\u03b3 monoclonal antibody blocks generation of virus\u2010specific cytotoxic T lymphocytes and virus elimination. Eur J Immunol. 1989;19:1283\u20138.","journal-title":"Eur J Immunol"},{"key":"5461_CR37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13046-021-02107-1","volume":"40","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang J, Li YJ, Yu NN, Liu WT, Liang JZ, et al. MEST promotes lung cancer invasion and metastasis by interacting with VCP to activate NF-\u03baB signaling. J Exp Clin Cancer Res. 2021;40:301.","journal-title":"J Exp Clin Cancer Res"},{"key":"5461_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cts.12117","volume":"7","author":"E Dec","year":"2014","unstructured":"Dec E, Rana P, Katheria V, Dec R, Khare M, Nalbandian A, et al. Cytokine profiling in patients with VCP-associated disease. Clin Transl Sci. 2014;7:29\u201332.","journal-title":"Clin Transl Sci"},{"key":"5461_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-2-2","volume":"2","author":"J De Larichaudy","year":"2012","unstructured":"De Larichaudy J, Zufferli A, Serra F, Isidori AM, Naro F, Dessalle K, et al. TNF-\u03b1- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet Muscle. 2012;2:2.","journal-title":"Skelet Muscle"},{"key":"5461_CR40","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","volume":"143","author":"JA Johnston","year":"1998","unstructured":"Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 1998;143:1883.","journal-title":"J Cell Biol"},{"key":"5461_CR41","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1182\/blood.V126.23.1350.1350","volume":"126","author":"ST Nawrocki","year":"2015","unstructured":"Nawrocki ST, Han Y, Le Moigne R, Visconte V, Przychodzen B, Rolfe M, et al. Activation of the unfolded protein response with the first-in-class P97 inhibitor CB-5083 induces stable disease regression and overcomes Ara-C resistance in AML. Blood 2015;126:1350.","journal-title":"Blood"},{"key":"5461_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1124\/jpet.120.000486","volume":"378","author":"H Leinonen","year":"2021","unstructured":"Leinonen H, Cheng C, Pitk\u00e4nen M, Sander CL, Zhang J, Saeid S, et al. A p97\/valosin-containing protein inhibitor drug CB-5083 has a potent but reversible off-target effect on phosphodiesterase-6. J Pharm Exp Ther. 2021;378:31\u201341.","journal-title":"J Pharm Exp Ther"},{"key":"5461_CR43","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1158\/1535-7163.MCT-22-0167","volume":"21","author":"AK LeBlanc","year":"2022","unstructured":"LeBlanc AK, Mazcko CN, Fan TM, Vail DM, Flesner BK, Bryan JN, et al. Comparative oncology assessment of a novel inhibitor of valosin-containing protein in tumor-bearing dogs. Mol Cancer Ther. 2022;21:1510\u201323.","journal-title":"Mol Cancer Ther"},{"key":"5461_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2006.12.206","volume":"354","author":"JMM M\u00fcller","year":"2007","unstructured":"M\u00fcller JMM, Deinhardt K, Rosewell I, Warren G, Shima DT. Targeted deletion of p97 (VCP\/CDC48) in mouse results in early embryonic lethality. Biochem Biophys Res Commun. 2007;354:459\u201365.","journal-title":"Biochem Biophys Res Commun"},{"key":"5461_CR45","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/genes13060963","volume":"13","author":"G Pfeffer","year":"2022","unstructured":"Pfeffer G, Lee G, Pontifex CS, Fanganiello RD, Peck A, Weihl CC, et al. Multisystem proteinopathy due to VCP mutations: a review of clinical heterogeneity and genetic diagnosis. Genes. 2022;13:963.","journal-title":"Genes"},{"key":"5461_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbamcr.2005.03.011","volume":"1744","author":"HH Meyer","year":"2005","unstructured":"Meyer HH. Golgi reassembly after mitosis: the AAA family meets the ubiquitin family. Biochim Biophys Acta. 2005;1744:108\u201319.","journal-title":"Biochim Biophys Acta"},{"key":"5461_CR47","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1128\/JVI.02039-06","volume":"81","author":"M Surjit","year":"2007","unstructured":"Surjit M, Jameel S, Lal SK. Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum. J Virol. 2007;81:3339\u201345.","journal-title":"J Virol"},{"key":"5461_CR48","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00705-016-3153-8","volume":"162","author":"S Bhowmick","year":"2017","unstructured":"Bhowmick S, Chakravarty C, Sellathamby S, Lal SK. The influenza A virus matrix protein 2 undergoes retrograde transport from the endoplasmic reticulum into the cytoplasm and bypasses cytoplasmic proteasomal degradation. Arch Virol. 2017;162:919\u201329.","journal-title":"Arch Virol"},{"key":"5461_CR49","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1099\/jgv.0.000828","volume":"98","author":"Z Yi","year":"2017","unstructured":"Yi Z, Yuan Z. Aggregation of a hepatitis C virus replicase module induced by ablation of p97\/VCP. J Gen Virol. 2017;98:1667\u201378.","journal-title":"J Gen Virol"},{"key":"5461_CR50","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1128\/JVI.01782-10","volume":"85","author":"G Pasqual","year":"2011","unstructured":"Pasqual G, Burri DJ, Pasquato A, Carlos De La Torre J, Kunz S. Role of the host cell\u2019s unfolded protein response in arenavirus infection. J Virol. 2011;85:1662\u201370.","journal-title":"J Virol"},{"key":"5461_CR51","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.omtn.2017.05.004","volume":"7","author":"T Meng","year":"2017","unstructured":"Meng T, Cao Q, Lei P, Bush AI, Xiang Q, Su Z, et al. Tat-haFGF 14-154 upregulates ADAM10 to attenuate the Alzheimer phenotype of APP\/PS1 mice through the PI3K-CREB-IRE1\u03b1\/XBP1 pathway. Mol Ther Nucleic Acids. 2017;7:439\u201352.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5461_CR52","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/hmg\/dds040","volume":"21","author":"RL Vidal","year":"2012","unstructured":"Vidal RL, Figueroa A, Court FA, Thielen P, Molina C, Wirth C, et al. Targeting the UPR transcription factor XBP1 protects against Huntington\u2019s disease through the regulation of FoxO1 and autophagy. Hum Mol Genet. 2012;21:2245\u201362.","journal-title":"Hum Mol Genet"},{"key":"5461_CR53","doi-asserted-by":"publisher","first-page":"e1000691","DOI":"10.1371\/journal.pgen.1000691","volume":"5","author":"MH Rajpar","year":"2009","unstructured":"Rajpar MH, McDermott B, Kung L, Eardley R, Knowles L, Heeran M, et al. Targeted induction of endoplasmic reticulum stress induces cartilage pathology. PLoS Genet. 2009;5:e1000691.","journal-title":"PLoS Genet"},{"key":"5461_CR54","doi-asserted-by":"publisher","first-page":"e73215","DOI":"10.7554\/eLife.73215","volume":"10","author":"A Roy","year":"2021","unstructured":"Roy A, Da Silva MT, Bhat R, Bohnert KR, Iwawaki T, Kumar A. The IRE1\/XBP1 signaling axis promotes skeletal muscle regeneration through a cell non-autonomous mechanism. Elife 2021;10:e73215.","journal-title":"Elife"},{"key":"5461_CR55","doi-asserted-by":"publisher","first-page":"e1008215","DOI":"10.1371\/journal.pgen.1008215","volume":"15","author":"KA Pir\u00f3g","year":"2019","unstructured":"Pir\u00f3g KA, Dennis EP, Hartley CL, Jackson RM, Soul J, Schwartz JM, et al. XBP1 signalling is essential for alleviating mutant protein aggregation in ER-stress related skeletal disease. PLoS Genet. 2019;15:e1008215.","journal-title":"PLoS Genet"},{"key":"5461_CR56","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.4049\/jimmunol.2000039","volume":"205","author":"DN Lisiero","year":"2020","unstructured":"Lisiero DN, Cheng Z, Tejera MM, Neldner BT, Warrick JW, Wuerzberger-Davis SM, et al. I\u03baB\u03b1 nuclear export enables 4\u20131BB induced cRel activation and IL-2 production to promote CD8 T cell immunity. J Immunol. 2020;205:1540.","journal-title":"J Immunol"},{"key":"5461_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuron.2013.02.029","volume":"78","author":"NC Kim","year":"2013","unstructured":"Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, et al. VCP is essential for mitochondrial quality control by PINK1\/Parkin and this function is impaired by VCP mutations. Neuron 2013;78:65.","journal-title":"Neuron"},{"key":"5461_CR58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2015.00016","volume":"9","author":"L Fang","year":"2015","unstructured":"Fang L, Hemion C, Pinho Ferreira Bento AC, Bippes CC, Flammer J, Neutzner A. Mitochondrial function in neuronal cells depends on p97\/VCP\/Cdc48-mediated quality control. Front Cell Neurosci. 2015;9:16.","journal-title":"Front Cell Neurosci"},{"key":"5461_CR59","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/cdd.2012.167","volume":"20","author":"PA Lang","year":"2013","unstructured":"Lang PA, Xu HC, Grusdat M, McIlwain DR, Pandyra AA, Harris IS, et al. Reactive oxygen species delay control of lymphocytic choriomeningitis virus. Cell Death Differ. 2013;20:649\u201358.","journal-title":"Cell Death Differ"},{"key":"5461_CR60","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1080\/15548627.2019.1569933","volume":"15","author":"K Arhzaouy","year":"2019","unstructured":"Arhzaouy K, Papadopoulos C, Schulze N, Pittman SK, Meyer H, Weihl CC. VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle. Autophagy 2019;15:1082\u201399.","journal-title":"Autophagy"},{"key":"5461_CR61","doi-asserted-by":"publisher","first-page":"5346483","DOI":"10.1155\/2020\/5346483","volume":"2020","author":"R Klein","year":"2020","unstructured":"Klein R, Nagy O, T\u00f3thov\u00e1 C, Chovanov\u00e1 F. Clinical and diagnostic significance of lactate dehydrogenase and its isoenzymes in animals. Vet Med Int. 2020;2020:5346483","journal-title":"Vet Med Int"},{"key":"5461_CR62","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.nmd.2016.05.017","volume":"26","author":"T Evangelista","year":"2016","unstructured":"Evangelista T, Weihl CC, Kimonis V, Lochm\u00fcller H, Clemen C, Deshaies R, et al. 215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13\u201315 November 2015, Heemskerk, The Netherlands. Neuromuscul Disord. 2016;26:535.","journal-title":"Neuromuscul Disord"},{"key":"5461_CR63","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1242\/jeb.041442","volume":"213","author":"SB Kanatous","year":"2010","unstructured":"Kanatous SB, Mammen PPA. Regulation of myoglobin expression. J Exp Biol. 2010;213:2741\u20137.","journal-title":"J Exp Biol"},{"key":"5461_CR64","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1096\/fj.08-128215","volume":"23","author":"P Klover","year":"2009","unstructured":"Klover P, Chen W, Zhu BM, Hennighausen L. Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a\/b: linking growth hormone to the androgen receptor. FASEB J. 2009;23:3140.","journal-title":"FASEB J"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05461-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05461-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05461-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T15:01:47Z","timestamp":1669906907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05461-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5461"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05461-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1015"}}